In the RNA-Seq Pipeline comparison on BL2 subsection of the Evaluation of RNA-Seq pipelines and cross-comparison with microarray subsection of the Results and discussion, there is an error in the third sentence of the fourth paragraph. The correct sentence is: It can be seen that P1(HTSeq) has the largest number of significant genes also found by others (169/287), which is 58.89% of the complete findings.
Shown are two Venn diagrams, one for each dataset (BL2 Fig 4A and RC Fig 4B). The different pipelines used here are: TopHat2 and Cufflinks (T&C), STAR and HTSeq-Count (S&HT), Sailfish (Sa), STAR and RSEM (S&R). The microarray data is not included, because there were close to no significant genes after FDR adjustment.
- 1. Wolff A, Bayerlová M, Gaedcke J, Kube D, Beißbarth T (2018) A comparative study of RNA-Seq and microarray data analysis on the two examples of rectal-cancer patients and Burkitt Lymphoma cells. PLoS ONE 13(5): e0197162. https://doi.org/10.1371/journal.pone.0197162 pmid:29768462
Citation: Wolff A, Bayerlová M, Gaedcke J, Kube D, Beißbarth T (2019) Correction: A comparative study of RNA-Seq and microarray data analysis on the two examples of rectal-cancer patients and Burkitt Lymphoma cells. PLoS ONE 14(10): e0224062. https://doi.org/10.1371/journal.pone.0224062
Published: October 24, 2019
Copyright: © 2019 Wolff et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.